| |
|
|
|
AC Immune SA  
|
|
7.81 0.35 (0.05%) |
11-20 16:00 |
|
Open: |
7.52 |
Pre close: |
7.46 |
Target:
|
9.29 
|
|
High: |
7.95 |
Low: |
7.44 |
Resistance:
|
7.95
9.29
|
|
Volume: |
125,250 |
Market Cap: |
528M |
Support:
|
5.98
4.77
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.23
|
MACD |
MACD(12,26):
|
0.56 |
|
MA(20): |
6.02 |
Signal(12,26,9): |
0.34 |
|
MA(100): |
5.42 |
Stochastic Oscillator |
%K(14,3):
|
91.79 |
|
MA(250): |
6.07  |
%D(3): |
92.74 |
|
Average Volume(K) |
3-Month: |
9474
|
52-Week |
High:
|
12.50 |
|
10-Days: |
10531 |
Low: |
3.25 |
|
RSI |
RSI(14):
|
84.87 |
Change(%): |
-25.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.550 |
Return on Equity (ttm) |
20.7 |
Shares Out. (M) |
67.56 |
|
EPS Est. Current Year |
-0.620 |
Return on Assets (ttm) |
11.7 |
Shares Float (M) |
26.17 |
|
EPS Est. Next Year |
-0.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
51.67 |
|
EPS Est. Next Quarter |
-0.130 |
Qtrly Rev. Growth |
1349.5 |
% Held by Institutions |
38.19 |
|
Forward EPS |
-0.970 |
Gross Profit (p.s.) |
-0.549 |
Shares Short (K) |
391 |
|
Book Value (p.s.) |
2.990 |
EBITDA (p.s.) |
0.000 |
P/E |
-14.20 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.61 |
|
Profit Margin |
45.09 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
